Evidence map›Paper›PMID 40454198›Full record

ArticleTetrahedron2025

Recent synthetic methodology advancements towards all-carbon quaternary center formation and applications.

Taotao Ling, Jose M Garfias, Sydney L Lawson, Fatima Rivas

Abstract read
In one paragraph

Article in Tetrahedron, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Taotao LingDepartment of Chemistry, Louisiana State University, 133 Choppin Hall, Baton Rouge, LA 70803, USA.
Jose M GarfiasDepartment of Chemistry, Louisiana State University, 133 Choppin Hall, Baton Rouge, LA 70803, USA.
Sydney L LawsonDepartment of Chemistry, Louisiana State University, 133 Choppin Hall, Baton Rouge, LA 70803, USA.
Fatima RivasDepartment of Chemistry, Louisiana State University, 133 Choppin Hall, Baton Rouge, LA 70803, USA.

Funding

Elucidating the mode of action of the abietanes to develop potential therapeutic agents_supplementR15GM148983 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI RIVAS, FATIMA R · 2022 to 2023
$467k
NIGMS NIH HHS R15 GM148983
6 · The paper itself

Abstract

The synthesis of organic molecules through regioselective and enantioselective processes represents a significant challenge in organic chemistry, but constructing molecules with all-carbon quaternary centers poses even greater complexity. The importance of synthetic organic chemistry in daily life cannot be overstated, as organic molecules are fundamental to human existence - from the nutrients that sustain us to the pharmaceutical products that maintain our health. Fundamental knowledge on chemical reactivity, particularly that of carbon-carbon bond formation in sterically hindered substrates, is of great interest in developing and studying new chemical matter. Increases in precision medicine have also highlighted the importance of molecular selectivity towards biological targets and the need to access complex molecular scaffolds with unique stereochemistry features such as quaternary carbon centers. The scarcity of molecules containing all-carbon quaternary centers has constrained our ability to fully explore their properties. This report examines recent methodological advances since 2019 in their synthesis, focusing on three key synthetic approaches: single electron transfer (SET) mediated reactions, reactions mediated by chemical phenomena associated with charge separation (electrochemistry), Lewis acid and transition metal mediated cyclization/rearrangement reactions. These innovative synthetic strategies open new pathways for creating complex chemical structures, advancing our ability to develop both novel therapeutic candidates and new materials. The enhanced efficiency of these approaches enables the exploration of increasingly sophisticated molecular architectures, expanding opportunities for discovering compounds with unique biological activities and material properties.

Identifiers

PMID40454198
PMCPMC12121990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.